Table 1 Comparison of clinical features between laparoscopic and open surgery groups
Clinical features | Laparoscopic surgery (n = 33) | Open surgery (n = 54) | p | |
|---|---|---|---|---|
Gender (n, %) | Female | 15 (45.45) | 28 (51.85) | 0.828 |
Male | 18 (54.55) | 26 (48.15) | ||
Onset age (months) | 22 (5, 44) | 39 (21, 84) | 0.008 | |
Primary site (n, %) | Adrenal | 32 (96.97) | 35 (64.81) | 0.001 |
Retroperitoneal | 1 (3.03) | 14 (25.93) | ||
Pelvic | 0 (0.00) | 5 (9.26) | ||
Maximum diameter of primary tumor (cm) | 3.06 (1.37) | 5.55 (2.77) | 0.009 | |
NSE (ng/mL) | 22.80 (19.70, 34.60) | 21.70 (19.00, 29.00) | 0.636 | |
LDH (U/L) | 260.00 (226.00, 303.00) | 244.00 (216.50, 295.50) | 0.764 | |
INPC (n, %) | Favorable | 24 (72.72) | 38 (70.37) | 0.813 |
Unfavorable | 9 (27.20) | 16 (29.63) | ||
MYCN status (n, %) | Not amplified | 30 (90.90) | 40 (74.07) | 0.129 |
Amplified | 2 (6.06) | 5 (9.26) | ||
Unknown | 1 (3.04) | 9 (16.67) | ||
1p (n, %) | Normal | 25 (75.75) | 39 (72.22) | 0.933 |
Aberration | 2 (6.06) | 5 (9.26) | ||
Unknown | 6 (18.19) | 10 (18.52) | ||
11q (n, %) | Normal | 24 (72.72) | 40 (74.07) | 0.962 |
Aberration | 3 (9.09) | 4 (7.41) | ||
Unknown | 6 (18.19) | 10 (18.52) | ||
INRG stage (n, %) | L1 | 24 (72.73) | 54 (100) | < 0.001 |
M | 4 (12.12) | 0 | ||
MS | 5 (15.15) | 0 | ||
INRG risk (n, %) | Very low | 27 (81.82) | 49 (90.74) | 0.098 |
Intermediate | 3 (9.09) | 0 | ||
High | 3 (9.09) | 5 (9.26) | ||